3Indexed trials
drug · Product Intelligence
Clopidogrel
Pipeline Intelligence
Clopidogrel: 3 indexed trials, 3 sponsors; 0 linked Orange Book patents and 16 FDA-linked events where matched.
3Sponsors
0Orange Book patent links
16FDA-linked events
Development evidence
NCT01924325Xijing Hospital · strokePHASE2, PHASE3
NCT03385538Zealand University Hospital · strokePHASE4
NCT06120725Kafrelsheikh University · strokePHASE3
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALCLOPIDOGREL BISULFATE · 2023-12-08
FDA_APPROVALCLOPIDOGREL BISULFATE · 2023-08-04
FDA_APPROVALCLOPIDOGREL BISULFATE · 2017-02-02
FDA_APPROVALCLOPIDOGREL BISULFATE · 2014-04-11
FDA_APPROVALCLOPIDOGREL BISULFATE · 2013-05-28
FDA_APPROVALCLOPIDOGREL BISULFATE · 2012-10-10
FDA_APPROVALCLOPIDOGREL BISULFATE · 2012-05-17
FDA_APPROVALCLOPIDOGREL BISULFATE · 2012-05-17
FDA_APPROVALCLOPIDOGREL BISULFATE · 2012-05-17
FDA_APPROVALCLOPIDOGREL BISULFATE · 2012-05-17
FDA_APPROVALCLOPIDOGREL BISULFATE · 2012-05-17
FDA_APPROVALCLOPIDOGREL BISULFATE · 2012-05-17
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.